» Articles » PMID: 38102637

Exploring the Interaction Between Extracellular Matrix Components in a 3D Organoid Disease Model to Replicate the Pathophysiology of Breast Cancer

Overview
Publisher Biomed Central
Specialty Oncology
Date 2023 Dec 15
PMID 38102637
Authors
Affiliations
Soon will be listed here.
Abstract

In vitro models are necessary to study the pathophysiology of the disease and the development of effective, tailored treatment methods owing to the complexity and heterogeneity of breast cancer and the large population affected by it. The cellular connections and tumor microenvironments observed in vivo are often not recapitulated in conventional two-dimensional (2D) cell cultures. Therefore, developing 3D in vitro models that mimic the complex architecture and physiological circumstances of breast tumors is crucial for advancing our understanding of the illness. A 3D scaffold-free in vitro disease model mimics breast cancer pathophysiology by allowing cells to self-assemble/pattern into 3D structures, in contrast with other 3D models that rely on artificial scaffolds. It is possible that this model, whether applied to breast tumors using patient-derived primary cells (fibroblasts, endothelial cells, and cancer cells), can accurately replicate the observed heterogeneity. The complicated interactions between different cell types are modelled by integrating critical components of the tumor microenvironment, such as the extracellular matrix, vascular endothelial cells, and tumor growth factors. Tissue interactions, immune cell infiltration, and the effects of the milieu on drug resistance can be studied using this scaffold-free 3D model. The scaffold-free 3D in vitro disease model for mimicking tumor pathophysiology in breast cancer is a useful tool for studying the molecular basis of the disease, identifying new therapeutic targets, and evaluating treatment modalities. It provides a more physiologically appropriate high-throughput platform for screening large compound library in a 96-384 well format. We critically discussed the rapid development of personalized treatment strategies and accelerated drug screening platforms to close the gap between traditional 2D cell culture and in vivo investigations.

Citing Articles

A Novel Microfluidic Platform for Personalized Anticancer Drug Screening Through Image Analysis.

Lipreri M, Totaro M, Boos J, Basile M, Baldini N, Avnet S Micromachines (Basel). 2025; 15(12.

PMID: 39770275 PMC: 11677617. DOI: 10.3390/mi15121521.


Plasma-Activated Medium Inhibited the Proliferation and Migration of Non-Small Cell Lung Cancer A549 Cells in 3D Culture.

Sun Z, Ding C, Wang Y, Lu T, Song W Int J Mol Sci. 2025; 25(24.

PMID: 39769029 PMC: 11676436. DOI: 10.3390/ijms252413262.


Establishment and characterization of endometrial organoids from different placental types.

Kwon D, Lim B, Lee S, Won S, Jang G BMB Rep. 2024; 58(2):95-103.

PMID: 39681412 PMC: 11875743.


Construction of a lung cancer 3D culture model based on alginate/gelatin micro-beads for drug evaluation.

Zhao Z, Feng X, Wu H, Chen S, Ma C, Guan Z Transl Lung Cancer Res. 2024; 13(10):2698-2712.

PMID: 39507032 PMC: 11535844. DOI: 10.21037/tlcr-24-490.


Advanced tumor organoid bioprinting strategy for oncology research.

Cui X, Jiao J, Yang L, Wang Y, Jiang W, Yu T Mater Today Bio. 2024; 28:101198.

PMID: 39205873 PMC: 11357813. DOI: 10.1016/j.mtbio.2024.101198.


References
1.
Guillen K, Fujita M, Butterfield A, Scherer S, Bailey M, Chu Z . A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nat Cancer. 2022; 3(2):232-250. PMC: 8882468. DOI: 10.1038/s43018-022-00337-6. View

2.
White L, Taylor A, Faulk D, Keane T, Saldin L, Reing J . The impact of detergents on the tissue decellularization process: A ToF-SIMS study. Acta Biomater. 2016; 50:207-219. PMC: 5592694. DOI: 10.1016/j.actbio.2016.12.033. View

3.
Callus B, Verhagen A, Vaux D . Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation. FEBS J. 2006; 273(18):4264-76. DOI: 10.1111/j.1742-4658.2006.05427.x. View

4.
Anthon S, Valente K . Vascularization Strategies in 3D Cell Culture Models: From Scaffold-Free Models to 3D Bioprinting. Int J Mol Sci. 2022; 23(23). PMC: 9737506. DOI: 10.3390/ijms232314582. View

5.
Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P . Breast cancer. Nat Rev Dis Primers. 2019; 5(1):66. DOI: 10.1038/s41572-019-0111-2. View